Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Leishmania LPG Kit ELISA

Kit ELISA Leishmania Leishmania LPG, test Colorimetric pour la quantification de Leishmania Leishmania LPG.
N° du produit ABIN997045

Aperçu rapide pour Leishmania LPG Kit ELISA (ABIN997045)

Antigène

Tous les produits Leishmania LPG (LPG)
Leishmania LPG (LPG) (Leishmania Lipophosphoglycan (LPG))

Reactivité

Leishmania

Méthode de détection

Colorimetric

Type de méthode

Competition ELISA

Application

ELISA

Type d'échantillon

Serum
  • Fonction

    The Leishmania ELISA Kit is for the screening of serum antibodies, primarily IgG, for visceral Leishmania using the ELISA technique.

    Analytical Method

    Qualitative

    Specificité

    97%

    Sensibilité

    84%
  • Volume d'échantillon

    10 μL

    Durée du test

    < 1 h

    Plaque

    Pre-coated

    Restrictions

    For Research Use only
  • Stock

    4 °C

    Date de péremption

    12 months
  • Antigène Tous les produits Leishmania LPG (LPG)

    Leishmania LPG (LPG) (Leishmania Lipophosphoglycan (LPG))

    Autre désignation

    Leishmania

    Classe de substances

    Species

    Sujet

    Visceral Leishmaniasis (VL) is a severe disease with high mortality, caused by parasite members of the L. donovani complex. The vector for transmission is the sand fly, whose carriers of infection are typically dogs. It is a disease endemic to many countries and is a serious problem in many developing nations, particularly with the increasing urbanization of populations. High incidence is encountered in parts of Latin America, East Africa, Middle East, India and China. It is endemic to countries bordering the Mediterranean such as Italy, Southern France, Spain, Portugal, and Northern Africa. In Southern Europe, VL has become the leading opportunistic infection in AIDS patients. Diagnosis of acute VL is often attempted by aspiration of bone marrow for direct parasite identification. The procedure is invasive, painful, dangerous and has a low success rate due to the inability to always isolate parasites from the tissue. Alternatively, serodiagnosis is widely utilized since anti-leishmanial antibody titers are typically high during the acute disease phase. ELISA is the preferred laboratory test for serodiagnosis of VL, although indirect immunofluorescent antibody tests (IFAT) and direct agglutination tests (DAT), using whole parasites, are still widely used in conjunction with ELISA or alone.
Vous êtes ici:
Chat with us!